Pfizer Stock Rises While Q4 Earnings Expected to Fall Sharply
• Pfizer (PFE) stock rose 0.7% on the day, outpacing the S&P 500, Dow, and Nasdaq • Pfizer is projected to report an EPS of -$0.18 and revenue of $14.3B on January 30th, representing decreases of 115.79% and 41.13% respectively • For the full year, EPS is expected to be $1.53 and revenue $58.67B, decreasing 76.75% and 41.53% • Pfizer currently has a Zacks Rank of #3 (Hold) and a Forward P/E ratio of 18.57 • The Large Cap Pharmaceuticals industry ranks in the top 22% out of over 250 industries, according to the Zacks Industry Rank